We previously reported that cetuximab can markedly downregulate the high basal levels of hypoxia-inducible factor-1 alpha (HIF-1α) by inhibiting HIF-1α protein synthesis in cancer cell lines that are sensitive to EGFR inhibition [14], [15]. The gene discussed is EGFR; the disease is cancer.